These findings suggest that PRDM15 potentially confers radioresistance and poor prognosis in rectal cancer; thus, a high PRDM15 level might predict inferior tumor regression and prognosis in locally advanced rectal cancer patients receiving preoperative radiotherapy. This evidence concerns the gene PRDM15 and neoplasm.